[{"address1": "2051 Ringwood Avenue", "city": "San Jose", "state": "CA", "zip": "95131", "country": "United States", "phone": "408 457 3700", "website": "https://www.ranitherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company, focusing on technologies to enable the administration of biologics and drugs orally for patients, physicians, and healthcare systems with a alternative to painful injections in the United States. The company develops the RaniPill capsule, a drug-agnostic oral delivery platform to deliver a variety of drug substances, including oligonucleotides, peptides, proteins, and antibodies. Its product pipeline includes RT-102, a parathyroid hormone that is in Phase I clinical trial for the treatment of osteoporosis; RT-105, an anti-TNF-alpha antibody that is in preclinical studies to treat psoriatic arthritis; RT-110, a parathyroid hormone for the treatment of hypoparathyroidism; RT-116 which is in discovery stage for the treatment of obesity; and RT-111, an ustekinumab biosimilar for the treatment of various inflammatory conditions. The has a collaboration agreement with ProGen Co., Ltd. for the o-development and commercialization of RT-114 to treat obesity. Rani Therapeutics Holdings, Inc. was founded in 2012 and is headquartered in San Jose, California.", "fullTimeEmployees": 105, "companyOfficers": [{"maxAge": 1, "name": "Mr. Mir A. Imran", "age": 67, "title": "Executive Chairman", "yearBorn": 1957, "fiscalYear": 2024, "totalPay": 40000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Talat  Imran", "age": 42, "title": "CEO & Director", "yearBorn": 1982, "fiscalYear": 2024, "totalPay": 105818, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Svai S. Sanford", "age": 54, "title": "Chief Financial Officer", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 416000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mir  Hashim", "age": 64, "title": "Chief Scientific Officer", "yearBorn": 1960, "fiscalYear": 2024, "totalPay": 416000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alireza  Javadi", "title": "Vice President of Technical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Eric  Groen J.D.", "age": 53, "title": "General Counsel", "yearBorn": 1971, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Bella  Vazquez", "title": "Vice President of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kate  McKinley M.B.A.", "age": 47, "title": "Chief Business Officer", "yearBorn": 1977, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Arvinder  Dhalla", "title": "Vice President of Clinical Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.07, "open": 1.07, "dayLow": 1.05, "dayHigh": 1.11, "regularMarketPreviousClose": 1.07, "regularMarketOpen": 1.07, "regularMarketDayLow": 1.05, "regularMarketDayHigh": 1.11, "payoutRatio": 0.0, "beta": 0.24, "forwardPE": -1.069307, "volume": 176805, "regularMarketVolume": 176805, "averageVolume": 839341, "averageVolume10days": 183300, "averageDailyVolume10Day": 183300, "bid": 1.08, "ask": 1.11, "bidSize": 1, "askSize": 1, "marketCap": 63508108, "fiftyTwoWeekLow": 1.02, "fiftyTwoWeekHigh": 7.88, "priceToSalesTrailing12Months": 61.778316, "fiftyDayAverage": 1.3365, "twoHundredDayAverage": 1.96283, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 39761612, "profitMargins": 0.0, "floatShares": 20849814, "sharesOutstanding": 33570300, "sharesShort": 2341795, "sharesShortPriorMonth": 2340699, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.0698, "heldPercentInsiders": 0.27793, "heldPercentInstitutions": 0.110190004, "shortRatio": 13.25, "shortPercentOfFloat": 0.0986, "impliedSharesOutstanding": 58803800, "bookValue": 0.06, "priceToBook": 18.000002, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -30018000, "trailingEps": -1.05, "forwardEps": -1.01, "enterpriseToRevenue": 38.679, "enterpriseToEbitda": -0.819, "52WeekChange": -0.85714287, "SandP52WeekChange": 0.09765589, "quoteType": "EQUITY", "currentPrice": 1.08, "targetHighPrice": 14.0, "targetLowPrice": 5.0, "targetMeanPrice": 9.5, "targetMedianPrice": 9.0, "recommendationKey": "none", "numberOfAnalystOpinions": 6, "totalCash": 27639000, "totalCashPerShare": 0.825, "ebitda": -48572000, "totalDebt": 29709000, "quickRatio": 1.411, "currentRatio": 1.495, "totalRevenue": 1028000, "debtToEquity": 850.53, "revenuePerShare": 0.036, "returnOnAssets": -0.65573996, "returnOnEquity": -3.91098, "grossProfits": 1028000, "freeCashflow": -15861625, "operatingCashflow": -35496000, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -10.93774, "financialCurrency": "USD", "symbol": "RANI", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Rani Therapeutics Holdings, Inc", "longName": "Rani Therapeutics Holdings, Inc.", "marketState": "CLOSED", "earningsTimestamp": 1743451500, "earningsTimestampStart": 1743451500, "earningsTimestampEnd": 1743451500, "earningsCallTimestampStart": 1743453000, "earningsCallTimestampEnd": 1743453000, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -1.05, "epsForward": -1.01, "epsCurrentYear": -0.85, "priceEpsCurrentYear": -1.2705883, "fiftyDayAverageChange": -0.2565, "fiftyDayAverageChangePercent": -0.1919192, "twoHundredDayAverageChange": -0.8828299, "twoHundredDayAverageChangePercent": -0.44977403, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-07-30", "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1746229633, "regularMarketTime": 1746216000, "exchange": "NGM", "messageBoardId": "finmb_242425883", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 0.9345785, "regularMarketPrice": 1.08, "postMarketChangePercent": 1.85185, "postMarketPrice": 1.1, "postMarketChange": 0.02, "regularMarketChange": 0.00999999, "regularMarketDayRange": "1.05 - 1.11", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 839341, "fiftyTwoWeekLowChange": 0.060000062, "fiftyTwoWeekLowChangePercent": 0.058823593, "fiftyTwoWeekRange": "1.02 - 7.88", "fiftyTwoWeekHighChange": -6.8, "fiftyTwoWeekHighChangePercent": -0.8629442, "fiftyTwoWeekChangePercent": -85.71429, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1627651800000, "displayName": "Rani Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-05-03"}]